Ignite Creation Date:
2025-12-24 @ 7:17 PM
Ignite Modification Date:
2025-12-30 @ 1:49 PM
Study NCT ID:
NCT01410903
Status:
TERMINATED
Last Update Posted:
2015-08-19
First Post:
2011-08-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Immunoadsorption in Patients With Severe Systemic Sclerosis
Sponsor:
GWT-TUD GmbH
Organization:
Study Overview
Official Title:
Immunoadsorption in Addition to the Established Therapy in Patients With Systemic Sclerosis
Status:
TERMINATED
Status Verified Date:
2015-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
inadequately recruitment rate, funding is not secured
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate source data for the survival and the investigation of the preliminary efficacy of immunoadsorption in patients with severe systemic sclerosis.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: